- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
ACTEMRA - 80mg/4ml - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AC07 | BioTech | Tocilizumab - 80mg/4ml | 5900 | 218156/09 | ACTEMRA | 80mg/4ml | 1 | Injectable concentrated solution | Infusion | Omnipharma | Chugai Pharma Manufacturing Co Ltd | Japan | 11,127,864 L.L | 21.26 | C | F. Hoffmann La Roche Ltd | Switzerland | 2/5/2024 | 0 |